• Support
  • Client Login
  • Learn More
  • Solutions
    • Prognos Oncology
    • Prognos Rare Disease
    • Commercial Analytics
    • Precision Marketing
  • About
    • Team
    • Become a Data Provider
    • Careers
    • News
    • Resources
  • Insights
    • Case Studies
      • LEMS
      • Lupus Nephritis
      • NSCLC
      • Oncology
      • Rare Disease
    • Webinar Series
  • Contact Us
Home Insights 5 Ways Life Science Brands Are Putting AI to Work

5 Ways Life Science Brands Are Putting AI to Work

  • October 17, 2017
  • Posted in AI

Healthcare AI delivers actionable insights to pharma companies by recognizing key trends and patterns useful for finding population segments that would benefit most from a particular therapy earlier in the process.

Read more in Prognos Lisa Kerber’s, LinkedIn blog.

« What’s Next in Pancreatic Cancer Screening
Diabetes and Rheumatoid Arthritis: A Missing Link? »

    Categories

    • AI (7)
    • Alerts (8)
    • artificial intelligence (1)
    • Blood Cancer (1)
    • Blood Cancer Awareness Month (1)
    • Breast Cancer (1)
    • Clinical (1)
    • Commercial Launch Excellence (8)
    • Compliance (1)
    • Conference (3)
    • diabetes (1)
    • diagnosis (1)
    • digital (1)
    • Disease Awareness (14)
    • Genomics Data (2)
    • HbA1c (1)
    • HCP omnichannel marketing (2)
    • healthcare AI (1)
    • IHC (1)
    • ISPOR (1)
    • Lab Testing Insights (27)
    • Lab Testing Trends (15)
    • Liquid Biopsy (1)
    • Marketplace (8)
    • NSCLC (1)
    • Omnichannel Marketing (8)
    • Oncology (3)
    • Patient Journey (7)
    • Rare Disease (3)
    • Reuters Pharma (1)
    • RWD Marketplace (3)
    • Sponsored Testing (1)
    see all topics
    • Products
      • Commercial Analytics
      • Oncology
      • Rare Disease
      • Precision Marketing
    • Company
      • Insights
      • Careers
      • News
    • Prognos Marketplace
      • Prognos Factor
    • Contact Us
    • Terms of Use
    • Privacy Policy
    • Site Map
    © Prognos Health, 2022. All Rights Reserved.